Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01935076 · ClinicalTrials.gov registry record
miRNA in Fetal Overgrowth
A clinical trial, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 82
- Enrollment target
NCT01935076: Completed study, sponsored by University of Pennsylvania.
NCT01935076 is a clinical trial that has completed, run by University of Pennsylvania. The registered enrollment target is 82 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01935076 has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 82 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether placental and umbilical cord blood miRNA expression is altered in women with obesity with macrosomic neonates to when compared to miRNA expression from control patients.
Interventions
- BEHAVIORAL Neonatal exposure to maternal obesity
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 82 participants |
| Start Date | 2013-01 |
| Est. Completion | 2014-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01935076
The ClinicalTrials.gov registry entry for NCT01935076 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 82 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Neonatal exposure to maternal obesity is the first listed.
NCT01935076 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01935076 about?
NCT01935076 is a clinical study titled "miRNA in Fetal Overgrowth". The purpose of this study is to determine whether placental and umbilical cord blood miRNA expression is altered in women with obesity with macrosomic neonates to when compared to miRNA expression from control patients.
What is the current status of trial NCT01935076?
This trial is currently completed. The enrollment target is 82 participants. The study started on 2013-01. Estimated completion is 2014-02.
What interventions are being tested in trial NCT01935076?
The interventions under investigation include: Neonatal exposure to maternal obesity (BEHAVIORAL).
Who is sponsoring clinical trial NCT01935076?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.